JP2015509500A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015509500A5 JP2015509500A5 JP2014558832A JP2014558832A JP2015509500A5 JP 2015509500 A5 JP2015509500 A5 JP 2015509500A5 JP 2014558832 A JP2014558832 A JP 2014558832A JP 2014558832 A JP2014558832 A JP 2014558832A JP 2015509500 A5 JP2015509500 A5 JP 2015509500A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- eye
- macular
- administered
- rectus muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims description 31
- 210000003205 muscle Anatomy 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 19
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 12
- 230000001886 ciliary effect Effects 0.000 claims description 10
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims description 8
- 210000000695 crystalline len Anatomy 0.000 claims description 8
- 201000011190 diabetic macular edema Diseases 0.000 claims description 8
- 210000001927 retinal artery Anatomy 0.000 claims description 8
- 210000001957 retinal vein Anatomy 0.000 claims description 8
- 208000024891 symptom Diseases 0.000 claims description 8
- 229940124597 therapeutic agent Drugs 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 5
- 201000004569 Blindness Diseases 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 210000002159 anterior chamber Anatomy 0.000 claims description 4
- 210000003161 choroid Anatomy 0.000 claims description 4
- 210000000795 conjunctiva Anatomy 0.000 claims description 4
- 210000004087 cornea Anatomy 0.000 claims description 4
- 210000001951 dura mater Anatomy 0.000 claims description 4
- 210000000554 iris Anatomy 0.000 claims description 4
- 208000018769 loss of vision Diseases 0.000 claims description 4
- 231100000864 loss of vision Toxicity 0.000 claims description 4
- 208000002780 macular degeneration Diseases 0.000 claims description 4
- 210000001328 optic nerve Anatomy 0.000 claims description 4
- 210000001747 pupil Anatomy 0.000 claims description 4
- 210000001525 retina Anatomy 0.000 claims description 4
- 230000002207 retinal effect Effects 0.000 claims description 4
- 210000003786 sclera Anatomy 0.000 claims description 4
- 230000035945 sensitivity Effects 0.000 claims description 4
- 210000003462 vein Anatomy 0.000 claims description 4
- 230000004393 visual impairment Effects 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 210000004240 ciliary body Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261601878P | 2012-02-22 | 2012-02-22 | |
| US61/601,878 | 2012-02-22 | ||
| US201261605576P | 2012-03-01 | 2012-03-01 | |
| US61/605,576 | 2012-03-01 | ||
| PCT/US2013/027175 WO2013126597A1 (en) | 2012-02-22 | 2013-02-21 | Methods and compositions for preventing or treating ophthalmic conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017111746A Division JP2017214380A (ja) | 2012-02-22 | 2017-06-06 | 眼疾患を予防または治療するための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015509500A JP2015509500A (ja) | 2015-03-30 |
| JP2015509500A5 true JP2015509500A5 (enExample) | 2016-04-07 |
Family
ID=49006208
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014558832A Pending JP2015509500A (ja) | 2012-02-22 | 2013-02-21 | 眼疾患を予防または治療するための方法および組成物 |
| JP2017111746A Pending JP2017214380A (ja) | 2012-02-22 | 2017-06-06 | 眼疾患を予防または治療するための方法および組成物 |
| JP2018189741A Pending JP2019034947A (ja) | 2012-02-22 | 2018-10-05 | 眼疾患を予防または治療するための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017111746A Pending JP2017214380A (ja) | 2012-02-22 | 2017-06-06 | 眼疾患を予防または治療するための方法および組成物 |
| JP2018189741A Pending JP2019034947A (ja) | 2012-02-22 | 2018-10-05 | 眼疾患を予防または治療するための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20150018288A1 (enExample) |
| EP (4) | EP3078384A1 (enExample) |
| JP (3) | JP2015509500A (enExample) |
| CN (2) | CN105343869A (enExample) |
| AU (3) | AU2013222423A1 (enExample) |
| CA (1) | CA2865317A1 (enExample) |
| HK (1) | HK1204988A1 (enExample) |
| WO (1) | WO2013126597A1 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115990242A (zh) | 2013-03-01 | 2023-04-21 | 康德生物医疗有限公司 | 预防或治疗巴斯综合征的方法和组合物 |
| CN117752766A (zh) * | 2013-03-01 | 2024-03-26 | 康德生物医疗有限公司 | 治疗线粒体疾病的方法 |
| WO2014209905A2 (en) | 2013-06-26 | 2014-12-31 | Stealth Peptides International, Inc. | Methods and compositions for detecting and diagnosing diseases and conditions |
| US20160193278A1 (en) * | 2013-08-01 | 2016-07-07 | Stealth Biotherapeutics Corp | Methods and compositions for preventing or treating leber's hereditary optic neuropathy |
| CN112457368A (zh) * | 2013-12-27 | 2021-03-09 | 康德生物医疗技术公司 | 药学相关的芳香族阳离子肽 |
| WO2015103577A1 (en) * | 2014-01-06 | 2015-07-09 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating dominant optic atrophy |
| CA2942143A1 (en) * | 2014-03-03 | 2015-09-11 | Stealth Biotherapeutics Corp | Pharmaceutically relevant aromatic-cationic peptides and methods of generating the same |
| CN106455563A (zh) * | 2014-03-03 | 2017-02-22 | 安可视觉公司 | 硫辛酸胆碱酯组合物及使用方法 |
| CA2978905A1 (en) | 2015-03-06 | 2016-09-15 | Stealth Biotherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
| CN109476700A (zh) * | 2016-03-11 | 2019-03-15 | 隐形生物治疗公司 | 结晶盐形式 |
| AU2017249218B2 (en) | 2016-04-11 | 2020-08-27 | Arcuate Therapeutics, Inc. | Chiral peptides |
| US11034724B2 (en) | 2017-04-05 | 2021-06-15 | Stealth Biotherapeutics Corp. | Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH2 |
| US10676506B2 (en) | 2018-01-26 | 2020-06-09 | Stealth Biotherapeutics Corp. | Crystalline bis- and tris-hydrochloride salt of elamipretide |
| AU2020219436A1 (en) * | 2019-02-08 | 2021-10-07 | Ohio State Innovation Foundation | Drug delivery compositions for ocular administration of therapeutics and methods of use thereof |
| EP3771467A1 (en) * | 2019-07-30 | 2021-02-03 | Fundacio Institut de Recerca de l'Hospital de la Santa Creu i sant Pau | Ss-31 for the prevention and/or treatment of aneurysm |
| KR102429281B1 (ko) * | 2020-05-25 | 2022-08-05 | (주)노바셀테크놀로지 | 신규 안구건조증 치료용 약학적 조성물 |
| US20240209038A1 (en) * | 2021-07-01 | 2024-06-27 | The Regents Of The University Of California | Targeting piezo1 to treat inherited and age-related macular degenerations |
| CN113975402B (zh) * | 2021-07-19 | 2023-05-16 | 河南大学 | 靶向脑缺血区线粒体的神经保护药物ss31-ha-qt及其荧光探针和应用 |
| KR20240108412A (ko) * | 2021-10-20 | 2024-07-09 | 스텔스 바이오테라퓨틱스 인코포레이티드 | 안과 병태를 치료하거나, 예방하거나, 억제하거나, 경감하거나 발병을 지연시키기 위한 방법 및 펩타이드 모방체를 포함하는 조성물 |
| CN115252555B (zh) * | 2022-06-07 | 2023-11-21 | 西安电子科技大学 | 一种膜融合性脂质体、制备方法及其在蛋白质递送中的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US781405A (en) | 1903-09-03 | 1905-01-31 | Marcus A Coykendall | Blank for dental plates. |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5674534A (en) | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5716644A (en) | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5989463A (en) | 1997-09-24 | 1999-11-23 | Alkermes Controlled Therapeutics, Inc. | Methods for fabricating polymer-based controlled release devices |
| CA2321560C (en) * | 1998-03-13 | 2007-05-22 | Johns Hopkins University School Of Medicine | The use of a protein tyrosine inhibitor such as genistein in the treatment of diabetic retinopathy or ocular inflammation |
| US6245740B1 (en) | 1998-12-23 | 2001-06-12 | Amgen Inc. | Polyol:oil suspensions for the sustained release of proteins |
| US6217896B1 (en) | 1999-04-01 | 2001-04-17 | Uab Research Foundation | Conjunctival inserts for topical delivery of medication or lubrication |
| CA2971928C (en) | 2004-01-23 | 2019-01-08 | Cornell Research Foundation, Inc. | Methods for reducing oxidative damage |
| EP3260127B1 (en) * | 2005-09-16 | 2019-05-01 | Cornell Research Foundation, Inc. | Aromatic-cationic peptide for use in a method of treating cerebral ischemia |
| ES2830024T3 (es) * | 2007-10-19 | 2021-06-02 | Novartis Ag | Composiciones y métodos para el tratamiento del edema macular |
| PL2252312T3 (pl) * | 2008-02-07 | 2014-10-31 | Univ Cornell | Sposoby zapobiegania lub leczenia insulinooporności |
| US20100081707A1 (en) * | 2008-02-21 | 2010-04-01 | Ali Robin R | Devices and methods for delivering polynucleotides into retinal cells of the macula and fovea |
| JP5677096B2 (ja) * | 2008-02-26 | 2015-02-25 | コーネル ユニヴァーシティー | 急性腎障害を予防および治療するための方法 |
| EP3150215A1 (en) * | 2009-08-24 | 2017-04-05 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating opthalmic conditions |
| AU2010325908A1 (en) * | 2009-12-04 | 2012-06-07 | Euclid Systems Corporation | Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| CN105879008A (zh) * | 2010-07-09 | 2016-08-24 | 康德生物医疗技术公司 | 预防或治疗缺血/再灌注损伤之后无复流的方法 |
-
2013
- 2013-02-21 EP EP16159631.7A patent/EP3078384A1/en not_active Withdrawn
- 2013-02-21 US US14/380,220 patent/US20150018288A1/en not_active Abandoned
- 2013-02-21 CN CN201510796422.9A patent/CN105343869A/zh active Pending
- 2013-02-21 CN CN201380021305.4A patent/CN104244964A/zh active Pending
- 2013-02-21 AU AU2013222423A patent/AU2013222423A1/en not_active Abandoned
- 2013-02-21 HK HK15105911.8A patent/HK1204988A1/xx unknown
- 2013-02-21 JP JP2014558832A patent/JP2015509500A/ja active Pending
- 2013-02-21 CA CA2865317A patent/CA2865317A1/en not_active Abandoned
- 2013-02-21 EP EP13751091.3A patent/EP2817018A4/en not_active Withdrawn
- 2013-02-21 EP EP17165829.7A patent/EP3281634A1/en not_active Withdrawn
- 2013-02-21 WO PCT/US2013/027175 patent/WO2013126597A1/en not_active Ceased
- 2013-02-21 EP EP18188192.1A patent/EP3479839A1/en not_active Withdrawn
-
2016
- 2016-01-07 US US14/990,349 patent/US20160361377A1/en not_active Abandoned
-
2017
- 2017-06-06 JP JP2017111746A patent/JP2017214380A/ja active Pending
- 2017-10-31 AU AU2017254849A patent/AU2017254849A1/en not_active Abandoned
- 2017-11-29 US US15/825,298 patent/US20180296630A1/en not_active Abandoned
-
2018
- 2018-10-05 JP JP2018189741A patent/JP2019034947A/ja active Pending
-
2019
- 2019-05-28 AU AU2019203713A patent/AU2019203713A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015509500A5 (enExample) | ||
| Lewis et al. | Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction | |
| Waszczykowska et al. | Prevalence of ocular manifestations in systemic sclerosis patients | |
| CN105050600A (zh) | 眼底疾病治疗剂 | |
| Zarei-Ghanavati et al. | Cataract and Diabetes: a review of the literature | |
| CN111109198B (zh) | 一种葡萄膜炎动物模型构建方法 | |
| RU2014151992A (ru) | Лечение воспалительных заболеваний глаз с применением лахинимода | |
| Kobashi et al. | Randomized comparison between rebamipide ophthalmic suspension and diquafosol ophthalmic solution for dry eye after penetrating keratoplasty | |
| Zheng et al. | Angle-closure glaucoma following periorbital botulinum toxin injection. | |
| Tamura et al. | A case report of pseudo-exfoliation syndrome with prolonged corneal epithelial regeneration because of erlotinib-induced unilateral corneal ulcer and anterior uveitis | |
| KOLLARITS et al. | Norepinephrine therapy of ischemic optic neuropathy | |
| JP2014510115A (ja) | 初期の緑内障における正常な視覚機能を回復するｐａｃａｐ（下垂体アデニル酸シクラーゼ活性化ポリペプチド）に基づく眼科用製剤 | |
| Ponomareva et al. | The effectiveness of local conservative therapy after panretinal laser coagulation against the background of diabetic neuropathy | |
| Yang et al. | Effect of anterior chamber paracentesis on initial treatment of acute angle closure | |
| Regenbogen et al. | Retinal detachments due to juxtapapillary microholes | |
| RU2558991C1 (ru) | Способ моделирования пролиферативной витреоретинопатии у крыс | |
| Berhuni et al. | Foveoschisis associated with gyrate atrophy in ornithine aminotransferase deficiency: a case report | |
| ALTAŞ | Angle Closure Glaucoma and Management in Geriatric Population | |
| Oga et al. | A Diagnosis of Occlusion | |
| Oga et al. | You're Getting on My Nerves | |
| RU2649534C1 (ru) | Способ анестезии при факоэмульсификации катаракты | |
| Lin | Observation on the clinical effect of cataract phacoemulsification combined with intraocular lens implantation | |
| Lamas et al. | Coats Disease in Young Patient with Congenital Cataracts History | |
| Huang et al. | Expression of inflammatory factors in aqueous humor of contralateral eyes after phacoemulsification in diabetes mellitus with cataract | |
| Watanabe et al. | Long-Term Progression of Fundus changes in Adults (1) |